HCR1011
To Encourage The United States Congress To Encourage The Use Of Unit Dose Packaging For Narcotics And Opioids To Preserve The Health And Safety Of All Citizens Of This Nation.
Last Action (March 17, 2023): Approved by the Governor
Sponsors
AI-Generated Summary
HCR 1011 is a concurrent resolution by the Arkansas General Assembly that encourages the United States Congress, the U.S. Food and Drug Administration (FDA), and the U.S. Drug Enforcement Administration (DEA) to promote the use of unit dose packaging for narcotics and opioids. The resolution cites the rise in drug overdose deaths as a motivation for this policy. It argues that unit dose packaging helps ensure medication integrity, improves patient compliance, prevents drug misuse, and reduces instances of diversion. The resolution suggests that this practice is practical and could potentially reduce medication waste for manufacturers. It does not mandate any changes under Arkansas state law but serves as a formal expression of the legislature's position. Once passed, copies will be sent to relevant federal officials and the Arkansas congressional delegation.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries include the general public, particularly patients prescribed opioids or narcotics, who would have better protection against accidental misuse or medication errors. Healthcare providers and pharmacists may also benefit from improved drug identification and simplified medication management. Additionally, the broader public could see a reduction in the societal costs associated with the opioid crisis, such as overdoses and illegal drug diversion.
Who Might Suffer?
Pharmaceutical manufacturers could be negatively impacted if they are required or pressured to transition to unit dose packaging, as this may increase their production, material, and logistical costs. Additionally, there is a potential for increased costs to be passed on to the healthcare system, insurance providers, or patients if unit dose packaging becomes a widespread requirement, due to the higher expense associated with individual packaging compared to bulk dispensing.
Get Notified
Receive an email when this bill's status changes.